BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11262124)

  • 1. Allylated monosaccharides as precursors in triple reductive amination strategies: synthesis of castanospermine and swainsonine.
    Zhao H; Hans S; Cheng X; Mootoo DR
    J Org Chem; 2001 Mar; 66(5):1761-7. PubMed ID: 11262124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of 5-azacastanospermine, a conformationally restricted azafagomine analogue.
    Søndergaard K; Liang X; Bols M
    Chemistry; 2001 Jun; 7(11):2324-31. PubMed ID: 11446635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of a sulfonium ion analogue of the glycosidase inhibitor swainsonine.
    Kumar NS; Pinto BM
    J Org Chem; 2006 Feb; 71(3):1262-4. PubMed ID: 16438551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of thiohydantoin-castanospermine glycomimetics as glycosidase inhibitors.
    Aguilar-Moncayo M; Mellet CO; García Fernández JM; García-Moreno MI
    J Org Chem; 2009 May; 74(9):3595-8. PubMed ID: 19334717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo asymmetric synthesis of 8a-epi-swainsonine.
    Abrams JN; Babu RS; Guo H; Le D; Le J; Osbourn JM; O'Doherty GA
    J Org Chem; 2008 Mar; 73(5):1935-40. PubMed ID: 18237188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generalized anomeric effect in action: synthesis and evaluation of stable reducing indolizidine glycomimetics as glycosidase inhibitors.
    Díaz Pérez VM; García Moreno MI; Ortiz Mellet C; Fuentes J; Díaz Arribas JC; Cañada FJ; García Fernández JM
    J Org Chem; 2000 Jan; 65(1):136-43. PubMed ID: 10813907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent cycloaddition and ring-closing metathesis approaches to indolizidine and pyrrolo[1,2-a]azepine skeletons from a chiral precursor: an expeditious route to (-)-8-epi-swainsonine triacetate.
    Nath M; Mukhopadhyay R; Bhattacharjya A
    Org Lett; 2006 Jan; 8(2):317-20. PubMed ID: 16408904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymmetric [2 + 2] cycloaddition: total synthesis of (-)-swainsonine and (+)-6-epicastanospermine.
    Ceccon J; Greene AE; Poisson JF
    Org Lett; 2006 Oct; 8(21):4739-42. PubMed ID: 17020291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 7-deoxy-6-epi-castanospermine, a trihydroxyindolizidine alkaloid glycosidase inhibitor from Castanospermum australe.
    Molyneux RJ; Tropea JE; Elbein AD
    J Nat Prod; 1990; 53(3):609-14. PubMed ID: 2213032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enantiospecific synthesis of 1-azafagomine.
    Ernholt BV; Thomsen Ib B; Lohse A; Plesner IW; Jensen KB; Hazell RG; Liang X; Jakobsen A; Bols M
    Chemistry; 2000 Jan; 6(2):278-87. PubMed ID: 11931107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient synthesis of (+)-1,8,8a-tri-epi-swainsonine, (+)-1,2-di-epi-lentiginosine, (+)-9a-epi-homocastanospermine and (-)-9-deoxy-9a-epi-homocastanospermine from a D-glucose-derived aziridine carboxylate, and study of their glycosidase inhibitory activities.
    Ajish Kumar KS; Chaudhari VD; Dhavale DD
    Org Biomol Chem; 2008 Feb; 6(4):703-11. PubMed ID: 18264570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. General approach to glycosidase inhibitors. Enantioselective synthesis of deoxymannojirimycin and swainsonine.
    Martín R; Murruzzu C; Pericàs MA; Riera A
    J Org Chem; 2005 Mar; 70(6):2325-8. PubMed ID: 15760222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of glycosylation inhibitors on the structure and function of the murine transferrin receptor.
    Ralton JE; Jackson HJ; Zanoni M; Gleeson PA
    Eur J Biochem; 1989 Dec; 186(3):637-47. PubMed ID: 2514095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo asymmetric synthesis of D- and L-swainsonine.
    Guo H; O'Doherty GA
    Org Lett; 2006 Apr; 8(8):1609-12. PubMed ID: 16597122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diels-Alder cycloaddition in the synthesis of 1-azafagomine, analogs, and derivatives as glycosidase inhibitors.
    Salgueiro DA; Sousa CE; Fortes AG; Alves MJ
    Mini Rev Med Chem; 2012 Dec; 12(14):1465-76. PubMed ID: 22827178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The comparative pathology of the glycosidase inhibitors swainsonine, castanospermine, and calystegines A3, B2, and C1 in mice.
    Stegelmeier BL; Molyneux RJ; Asano N; Watson AA; Nash RJ
    Toxicol Pathol; 2008 Jul; 36(5):651-9. PubMed ID: 18497426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of castanospermine and swainsonine on the activity and synthesis of intestinal sucrase.
    Pan YT; Ghidoni J; Elbein AD
    Arch Biochem Biophys; 1993 May; 303(1):134-44. PubMed ID: 8489256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New synthetic approach to enantiopure bicyclic sulfonium salts: swainsonine analogues.
    Cerè V; Pollicino S; Ricci A
    J Org Chem; 2003 Apr; 68(8):3311-4. PubMed ID: 12688809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of isourea-type glycomimetics related to the indolizidine and trehazolin glycosidase inhibitor families.
    García-Moreno MI; Díaz-Pérez P; Ortiz Mellet C; García Fernández JM
    J Org Chem; 2003 Nov; 68(23):8890-901. PubMed ID: 14604359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of sulfamide-type indolizidines as glycosidase inhibitors.
    Benltifa M; García Moreno MI; Ortiz Mellet C; García Fernández JM; Wadouachi A
    Bioorg Med Chem Lett; 2008 May; 18(9):2805-8. PubMed ID: 18420407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.